Trial Profile
Optimization of Clinical Treatment Schemes for Multidrug - resistant Pulmonary Tuberculosis Based on Host - mediate
Status:
Recruiting
Phase of Trial:
Phase IV
Latest Information Update: 25 Oct 2016
Price :
$35
*
At a glance
- Drugs Zileuton (Primary)
- Indications Tuberculosis
- Focus Therapeutic Use
- 25 Oct 2016 New trial record